Induction of epithelial neoplasms in the ovaries of guinea pigs by estrogenic stimulation

Gynecologic Oncology

Volumn 71, Issue 2, 1998, Pages 240-246

  Silva, E G ^a   Tornos, C ^a   Deavers, M ^a   Kaisman, K ^a   Gray, K ^a   Gershenson, D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Estrogens; Guinea pigs; Ovarian neoplasms

Indexed keywords

ESTRADIOL; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTAMINATION; CONTROLLED STUDY; CYSTADENOMA; EPITHELIUM TUMOR; ESTROGEN SYNTHESIS; GENE INDUCTION; GUINEA PIG; HORMONAL REGULATION; NONHUMAN; OVARY TUMOR; OVULATION; PAPILLOMA; PRIORITY JOURNAL;

EID: 0032213196     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5153     Document Type: Article

References (21)

1. Fathalla M F. Incessant ovulation: A factor in ovarian neoplasia? [letter]. Lancet. 2:1971;163.
2. Cramer D W, Welch W R. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 71:1983;717-721.
3. Cramer D W, Welch W R, Cassells S, Scully R E. Mumps, menarche, menopause, and ovarian cancer. Am J Obstet Gynecol. 147:1983;1-6.
4. Henderson B E, Ross R K, Pike M C, Casagrande J T. Endogenous hormones as a major factor in human cancer. Cancer Res. 42:1982;3232-3239.
5. Morrow G P, Townsend D E. Synopsis of Gynecologic Oncology. 1987;Wiley, New York. p. 231-234.
6. Silva E G, Tornos C, Fritsche H A Jr, El-Naggar A, Gray K, Ordonez N G, Luna M, Gershenson D. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: A potential animal model. Mod Pathol. 10:1997;879-883.
7. Spontaneous Ovarian Tumors in Laboratory Animals, in Biology of Ovarian Neoplasia: A series of Workshops on the Biology of Human Cancer, 1980, 51, 65.
8. Manning P J. Neoplastic Diseases. Wagner J E, Manning P J. The Biology of the Guinea Pigs. 1976;211-225 Academic Press, New York.
9. Jambhekar N A, Sampat M B. Simultaneous endometrioid carcinoma of the uterine corpus and ovary: A clinicopathologic study of 15 cases. J Surg Oncol. 37:1988;20-23.
10. Prat J, Matias-Guiu X, Barreto J. Simultaneous carcinoma involving the endometrium and the ovary: A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases. Cancer. 68:1991;2455-2459.
11. Ulbright T M, Roth L M. Metastatic and independent cancers of the endometrium and ovary: A clinicopathologic study of 34 cases. Hum Pathol. 16:1985;28-34.
12. Mooney J, Silva E, Tornos C, Gershenson D. Unusual features of serous neoplasms of low malignant potential during pregnancy. Gynecol Oncol. 65:1997;30-35.
13. Bartnik J, Powell W AS, Moriber-Katz S, Amenta P S. Metaplastic papillary tumor of the fallopian tube: Case report, immunohistochemical features, and review of the literature. Arch Pathol Lab Med. 113:1989;545-547.
14. Keeney G I, Thrasher V. Metaplastic papillary tumor of the fallopian tube: A case report with ultrastructure. Int J Gynecol Pathol. 7:1988;86-92.
15. Whittemore A S, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 U.S. case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol. 136:1992;1184-1203.
16. Slotman B J, Rao B R. Ovarian cancer: Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy, and endocrine therapy. Anticancer Res. 8:1988;417-434.
17. Harlow B L, Weiss N S, Roth G I, Chu J, Daling J R. Case-control study of borderline ovarian tumors: Reproductive history and exposure to exogenous female hormones. Cancer Res. 48:1988;5849-5852.
18. Frederickson T N. Ovarian tumors of the hen. Environ Health Perspect. 73:1987;35-51.
19. Jabara A G. Canine ovarian tumours following stilboestrol administration. Aust J Exp Biol. 37:1959;549-566.
20. Jabara A G. Induction of canine ovarian tumours by diethylstilbestrol and progresterone. Aust J Exp Biol. 40:1962;139-152.
21. Owen N V, Pierce E C, Anderson R C. Papillomatous growths on internal genitalia of bitches administered the synthetic estrogentrans. Toxicol Appl Pharmacol. 21:1972;582-585.